{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:37:05Z","timestamp":1793813825916,"version":"4.6.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":1408,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1111\/jth.14324","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T06:44:08Z","timestamp":1541400248000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Sulodexide in venous disease"],"prefix":"10.1016","volume":"17","author":[{"given":"B.J.","family":"Carroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.Z.","family":"Goldhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14324_bb0010","first-page":"243","article-title":"Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects","volume":"33","author":"Masola","year":"2014","journal-title":"Int Angiol"},{"key":"10.1111\/jth.14324_bb0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/DDDT.S6762","article-title":"Development and use of sulodexide in vascular diseases: implications for treatment","volume":"8","author":"Coccheri","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"10.1111\/jth.14324_bb0020","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1742-4658.2012.08529.x","article-title":"Glycosaminoglycans: key players in cancer cell biology and treatment","volume":"279","author":"Afratis","year":"2012","journal-title":"FEBS J"},{"key":"10.1111\/jth.14324_bb0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2018.01.026","article-title":"Endothelial cell dysfunction and glycocalyx \u2013 a viscious circle","volume":"72","author":"Zhang","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1111\/jth.14324_bb0030","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI119377","article-title":"Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?","volume":"99","author":"Rosenberg","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.14324_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpba.2018.04.012","article-title":"Fine structural characterization of sulodexide","volume":"156","author":"Veraldi","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"10.1111\/jth.14324_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1128(199801)18:1<1::AID-MED1>3.0.CO;2-4","article-title":"Review of pharmacodynamics, pharmacokinetics and therapeutic properties of sulodexide","volume":"18","author":"Harenberg","year":"1998","journal-title":"Med Res Rev"},{"key":"10.1111\/jth.14324_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-2007-1001914","article-title":"Human pharmacokinetics of glycosaminoglycans using deuterium\u2010labeled and unlabeled substances: evidence for oral absorption","volume":"20","author":"Silvestro","year":"1994","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14324_bb0050","doi-asserted-by":"crossref","first-page":"e48632","DOI":"10.1371\/journal.pone.0048632","article-title":"On the specificity of heparin\/heparan sulfate binding to proteins. Anion\u2010binding sites on antithrombin and thrombin are fundamentally different","volume":"7","author":"Mosier","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.14324_bb0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1877-1173(10)93015-9","article-title":"Vascular dermatan sulphate and heparin cofactor\u00a0II","volume":"93","author":"Tollefsen","year":"2010","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1111\/jth.14324_bb0060","first-page":"161","article-title":"Pharmacokinetics of sulodexide evaluation from 131\u2010labelled fast\u2010moving heparin after single intravenous and oral administration on man at different doses","volume":"3","author":"Milani","year":"1992","journal-title":"Br J Clin Res"},{"key":"10.1111\/jth.14324_bb0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-2007-1001916","article-title":"Organ glycosaminoglycan distribution after intravenous and oral administration in rats","volume":"20","author":"Marchi","year":"1994","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14324_bb0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0049-3848(03)00246-9","article-title":"Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans","volume":"109","author":"Cosmi","year":"2003","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14324_bb0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02591420","article-title":"Antithrombotic and thrombolytic activity of sulodexide in rats","volume":"22","author":"Barbanti","year":"1992","journal-title":"Int J Clin Lab Res"},{"key":"10.1111\/jth.14324_bb0080","first-page":"342","article-title":"Profibrinolytic and antithrombotic effects of sulodexide oral administration: a double\u2010blind, cross\u2010over, placebo\u2010controlled study","volume":"51","author":"Mauro","year":"1992","journal-title":"Curr Ther Res"},{"key":"10.1111\/jth.14324_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-2007-1001909","article-title":"Interaction between glycosaminoglycans, platelets, and leukocytes","volume":"20","author":"Cerletti","year":"1994","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14324_bb0090","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.thromres.2006.10.026","article-title":"The anti\u2010inflammatory effects of heparin and related compounds","volume":"122","author":"Young","year":"2008","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14324_bb0095","doi-asserted-by":"crossref","first-page":"E2206","DOI":"10.3390\/ijms18102206","article-title":"Chronic venous insufficiency: transforming growth factor\u2010beta isoforms and soluble endoglin concentration in different states of wound healing","volume":"18","author":"Ligi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1111\/jth.14324_bb0100","first-page":"236","article-title":"Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease","volume":"33","author":"Mannello","year":"2014","journal-title":"Int Angiol"},{"key":"10.1111\/jth.14324_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1570161111666131126144025","article-title":"Sulodexide down\u2010regulates the release of cytokines, chemokines, and leukocyte colony stimulating factors from human macrophages: role of glycosaminoglycans in inflammatory pathways of chronic venous disease","volume":"12","author":"Mannello","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1111\/jth.14324_bb0110","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.bbadis.2016.07.018","article-title":"Chronic venous disease \u2013 part I: inflammatory biomarkers in wound healing","volume":"1862","author":"Ligi","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/jth.14324_bb0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.trsl.2008.12.007","article-title":"Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity","volume":"153","author":"Ciszewicz","year":"2009","journal-title":"Transl Res"},{"key":"10.1111\/jth.14324_bb0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejphar.2011.05.059","article-title":"Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats","volume":"15","author":"Jin","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/jth.14324_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-10-213","article-title":"A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase\u20101 and prevents FGF\u20102\u2010induced renal epithelial\u2013mesenchymal transition","volume":"10","author":"Masola","year":"2012","journal-title":"J Transl Med"},{"key":"10.1111\/jth.14324_bb0130","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/ATVBAHA.112.254961","article-title":"Macrophage activation by heparanase is mediated by TLR\u20102 and TLR\u20104 and associates with plaque progression","volume":"33","author":"Blich","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14324_bb0135","first-page":"255","article-title":"Role of sulodexide in the treatment of CVD","volume":"33","author":"Andreozzi","year":"2014","journal-title":"Int Angiol"},{"key":"10.1111\/jth.14324_bb0140","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2174\/1570161111311030010","article-title":"Glycosaminoglycan sulodexide inhibition of MMP\u20109 gelatinase secretion and activity: possible pharmacological role against collagen degradation in\u00a0vascular chronic diseases","volume":"11","author":"Mannello","year":"2013","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1111\/jth.14324_bb0145","first-page":"149","article-title":"Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research","volume":"3","author":"Mannello","year":"2011","journal-title":"Am J Transl Res"},{"key":"10.1111\/jth.14324_bb0150","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.bbadis.2016.07.011","article-title":"Chronic venous disease \u2013 part II: proteolytic biomarkers in wound healing","volume":"1862","author":"Ligi","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/jth.14324_bb0155","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s00125-010-1910-x","article-title":"Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type\u00a02 diabetes mellitus","volume":"53","author":"Broekhuizen","year":"2010","journal-title":"Diabetologia"},{"key":"10.1111\/jth.14324_bb0160","doi-asserted-by":"crossref","first-page":"491","DOI":"10.33549\/physiolres.931506","article-title":"Sulodexide improves endothelial dysfunction in streptozotocin\u2010induced diabetes in rats","volume":"57","author":"Kristova","year":"2008","journal-title":"Physiol Res"},{"key":"10.1111\/jth.14324_bb0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/08977199409011002","article-title":"Mesoglycan and sulodexide act as stabilizers and protectors of fibroblast growth factors (FGFs)","volume":"11","author":"Tardieu","year":"1994","journal-title":"Growth Factors"},{"key":"10.1111\/jth.14324_bb0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0021-9150(90)90071-P","article-title":"Double\u2010blind multicenter trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use","volume":"81","author":"Crepaldi","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1111\/jth.14324_bb0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.annepidem.2004.05.015","article-title":"The epidemiology of chronic venous insufficiency and varicose veins","volume":"15","author":"Beebe\u2010Dimmer","year":"2005","journal-title":"Ann Epidemiol"},{"key":"10.1111\/jth.14324_bb0180","first-page":"161","article-title":"Socio\u2010economic impact of chronic venous insufficiency. An underestimated public health problem","volume":"17","author":"Van den Oever","year":"1998","journal-title":"Int Angiol"},{"issue":"Suppl. S","key":"10.1111\/jth.14324_bb0185","doi-asserted-by":"crossref","first-page":"68S","DOI":"10.1016\/j.jvs.2007.08.048","article-title":"Secondary chronic venous disorders","volume":"46","author":"Meissner","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1111\/jth.14324_bb0190","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/0268355514530277","article-title":"The distribution and extent of reflux and obstruction in patients with active venous ulceration","volume":"30","author":"Kanth","year":"2015","journal-title":"Phlebology"},{"key":"10.1111\/jth.14324_bb0195","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/ars.2013.5624","article-title":"Mechanotransduction in the endothelium: role of membrane proteins and reactive oxygen species in sensing, transduction, and transmission of the signal with altered blood flow","volume":"20","author":"Chatterjee","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1111\/jth.14324_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.00524","article-title":"Endothelial mechanotransduction, redox signaling and the regulation of vascular inflammatory pathways","volume":"9","author":"Chatterjee","year":"2018","journal-title":"Front Physiol"},{"key":"10.1111\/jth.14324_bb0205","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0741-5214(97)70091-0","article-title":"Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency","volume":"26","author":"Pappas","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.1111\/jth.14324_bb0210","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMra055289","article-title":"Chronic venous disease","volume":"355","author":"Bergan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14324_bb0215","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1007\/s12325-016-0359-9","article-title":"Sulodexide in patients with chronic venous disease of the lower limbs: clinical efficacy and impact on quality of life","volume":"33","author":"Elleuch","year":"2016","journal-title":"Adv Ther"},{"key":"10.1111\/jth.14324_bb0220","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1111\/jth.14324_bb0225","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/01.RES.86.1.e13","article-title":"Mechanisms for regulation of fluid shear stress response in circulating leukocytes","volume":"86","author":"Fukuda","year":"2000","journal-title":"Circ Res"},{"key":"10.1111\/jth.14324_bb0230","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/10739680801904174","article-title":"Fluid shear attenuates endothelial pseudopodia formation into the capillary lumen","volume":"15","author":"Hueck","year":"2008","journal-title":"Microcirculation"},{"key":"10.1111\/jth.14324_bb0235","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1073\/pnas.94.10.5338","article-title":"The leukocyte response to fluid stress","volume":"94","author":"Moazzam","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14324_bb0240","doi-asserted-by":"crossref","first-page":"h1387","DOI":"10.1152\/ajpheart.01003.2000","article-title":"Enhancement of reperfusion injury by elevation of microvascular pressures","volume":"282","author":"Takase","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1111\/jth.14324_bb0245","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S0049-3848(09)70147-1","article-title":"Dermal pathology, cellular biology, and inflammation in chronic venous disease","volume":"123","author":"Raffetto","year":"2009","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14324_bb0250","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejvs.2010.09.025","article-title":"Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions","volume":"41","author":"Perrin","year":"2011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1111\/jth.14324_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19061669","article-title":"Pathophysiological mechanisms of chronic venous disease and implications for venoactive drug therapy","volume":"19","author":"Mansilha","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1111\/jth.14324_bb0260","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jvsv.2015.10.002","article-title":"Pharmacologic treatment to improve venous leg ulcer healing","volume":"4","author":"Raffetto","year":"2016","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1111\/jth.14324_bb0265","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1185\/03007999209115223","article-title":"Sulodexide and the microcirculatory component in microphlebopathies","volume":"13","author":"Cospite","year":"1992","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/jth.14324_bb0270","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1185\/03007999309111538","article-title":"Double\u2010blind, double\u2010dummy, randomized, multi\u2010centre clinical assessment of the efficacy, tolerability and dose\u2013effect relationship of sulodexide in chronic venous insufficiency","volume":"13","author":"Saviano","year":"1993","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/jth.14324_bb0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2006.12.009","article-title":"Sulodexide induces hepatocyte growth factor release in humans","volume":"558","author":"Borawski","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/jth.14324_bb0280","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ndt\/gfr370","article-title":"Oral supplementation with sulodexide inhibits neo\u2010angiogenesis in a rat model of peritoneal perfusion","volume":"27","author":"Pletinck","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jth.14324_bb0285","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/000331979905001102","article-title":"Treatment of venous leg ulcers with sulodexide","volume":"50","author":"Scondotto","year":"1999","journal-title":"Angiology"},{"key":"10.1111\/jth.14324_bb0290","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1613116","article-title":"Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers","volume":"87","author":"Coccheri","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14324_bb0295","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0037-1621458","article-title":"Treatment of venous leg ulcers with sulodexide","volume":"32","author":"Kucharzweski","year":"2003","journal-title":"Phlebologie"},{"key":"10.1111\/jth.14324_bb0300","first-page":"22","article-title":"Efficacy and safety of sulodexide in the treatment of venous ulcers of leg","volume":"7","author":"Zhou","year":"2007","journal-title":"Pharm Care Res"},{"key":"10.1111\/jth.14324_bb0305","first-page":"1902","article-title":"Venous leg ulcers","volume":"2008","author":"Nelson","year":"2008","journal-title":"BMJ Clin Evid"},{"key":"10.1111\/jth.14324_bb0310","doi-asserted-by":"crossref","first-page":"454S","DOI":"10.1378\/chest.08-0658","article-title":"Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence\u2010based clinical practice guidelines (8th edition)","volume":"133","author":"Kearon","year":"2008","journal-title":"Chest"},{"key":"10.1111\/jth.14324_bb0315","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2011.01.079","article-title":"The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum","volume":"53","author":"Gloviczki","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1111\/jth.14324_bb0320","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/1076029614533143","article-title":"The efficacy of sulodexide in the prevention of postthrombotic syndrome","volume":"20","author":"Luzzi","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/jth.14324_bb0325","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/000331970405500302","article-title":"Prevention of recurrent deep venous thrombosis with sulodexide: the SanVal registry","volume":"55","author":"Errichi","year":"2004","journal-title":"Angiology"},{"key":"10.1111\/jth.14324_bb0330","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/000331970605700108","article-title":"A study on the safety, efficacy, and efficiency of sulodexide compared with acenocoumarol in secondary prophylaxis in patients with deep venous thrombosis","volume":"57","author":"Cirujeda","year":"2006","journal-title":"Angiology"},{"key":"10.1111\/jth.14324_bb0335","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.115.016930","article-title":"Sulodexide for the prevention of recurrent venous thromboembolism: the sulodexide in secondary prevention of recurrent deep vein thrombosis (SURVET) study: a multicenter, randomized, double\u2010blind, placebo\u2010controlled trial","volume":"132","author":"Andreozzi","year":"2015","journal-title":"Circulation"},{"key":"10.1111\/jth.14324_bb0340","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1373\/clinchem.2014.234088","article-title":"Is venous thromboembolism a chronic inflammatory disease?","volume":"61","author":"Piazza","year":"2015","journal-title":"Clin Chem"},{"key":"10.1111\/jth.14324_bb0345","doi-asserted-by":"crossref","first-page":"91350","DOI":"10.18632\/oncotarget.20518","article-title":"Sulodexide recovers endothelial function through reconstructing glycocalyx in the balloon\u2010injury rat carotid artery model","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1111\/jth.14324_bb0350","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1586\/14779072.2015.1000306","article-title":"Prevention and treatment of the post\u2010thrombotic syndrome and of the chronic thromboembolic pulmonary hypertension","volume":"13","author":"Pesavento","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14324","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14324","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14324","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622030252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622030252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:25:08Z","timestamp":1761535508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622030252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1538783622030252"],"URL":"https:\/\/doi.org\/10.1111\/jth.14324","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulodexide in venous disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}